WIRB-Copernicus launches product aimed at institutions and research sites

Businessman video-chats with doctor on laptop
WIRB-Copernicus Group launched a new product aimed at upping the efficiency and profitability of clinical research operators at institutions and independent research sites. (Getty/AndreyPopov)

Clinical trial specialist WIRB-Copernicus Group launched a new product aimed at upping the efficiency and profitability of clinical research operators at institutions and independent research sites.

Dubbed SiteReady, the product is an end-to-end solution designed to make research more efficient and easier to manage by reducing the administrative burden of regulatory compliance, streamlining contract and budget negotiations, speeding up study start-up and builds patient enrollment in clinical trials.

“The research ecosystem is changing rapidly; protocols are increasingly complex, research teams are stretched thin, and patients are more informed than ever,” Donald Deieso, chair and CEO of WCG, said in a statement. “Biopharmaceutical companies are seeking investigators who can perform clinical studies at the highest level of efficiency and integrity.

Webinar

Lipid-based Formulations for Early Stage Clinical Trials

Liquid-filled capsule technology has a proven record for addressing complex API formulation challenges, but also offers a simple and effective pathway to the clinic. Register now to learn more about lipid-based formulations.

“Conversely, leading investigative sites desire opportunities to participate in the exciting advances being developed by the industry. To succeed in this highly competitive landscape, investigators and site teams must continually position themselves for growth.”

Earlier this year WCG upped its presence in the clinical trial management solutions business with the addition of CTMS specialist Velos eResearch. That deal fell six months after WCG snapped up KMR Group and Metrics Consortium in an acquisition, bolstering is market insights and intelligence division.

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.